Font Size: a A A
Keyword [CD19 CAR-T]
Result: 1 - 20 | Page: 1 of 2
1. The Construction Of CD19-CAR-T Cell And The Effect Of CD19-CAR-T Cell On CD19 Positive Hematological Malignancies
2. The Effect Of Hucmscs And Hcbmscs On T Lymphocyte Subsets
3. The Experimental Research About The Effection Of CD19 Chimeric Antigen Receptor T-Cell With Chemotherapy Drugs
4. The Preliminary Study Of The Novel CAR-T Function Of IL-21-CCL19
5. Study On The Function Of αCD19-CAR-T By Silencing Of ACAT1 Gene
6. Basic And Clinical Study On CD19-CAR-T Cells For B Cell Non-hodgkin Lymphoma
7. Efficacy And Safety Of CD19 CAR-T Cells In Refractory/Recurrent Acute B-Lymphoblastic Leukemia:A Meta-analysis
8. Optimization Of Gene Editing Conditions For CRISPR/Cas9 And Its Application In The Construction Of Universal CD19.CAR-T Cells
9. Anti-tumor Effect Of Nanobody-based CD19 CAR-T Cells
10. Changes Of Cytokine Levels After Relapsed/refractory B-ALL Treated With CD19 CAR-T Cells And Its Clinical Significance
11. Studies On The Abilities And Safety Of Anti-CD19 Chimeric Antigen Receptor T Cells In Killing Lymphomain Vivo
12. Efficacy And Safety Of CD19 CAR T Cells In The Treatment Of Relapsed And Refractory Acute B Lymphocytic Leukemia With Central Nervous System Invasion
13. Study Of T-cell Subsets In Peripheral Blood Of B-cell Acute Lymphoblastic Leukemia Patients And Their Effect On CD19 CAR-T Cell Therapy
14. Clinical Study On Donor-derived Targeting CD19 CAR-T Cells For The Treatment Of Relapsed CD19~+ B-cell Acute Lymphoblastic Leukemia After Hematopoietic Stem Cell Transplantation
15. Study On The Prognosis Evaluation And Treatment Strategy Of Acute Leukemia
16. A Clinical Study Of Fourth-generation CD19-CAR T-cells In The Threapy Of Relapsed/Refractory Adult Acute B Lymphocytic Leukemia
17. The Effect Of C-Jun Overexpression On The Function Of Cord Blood Derived CD19.CAR-T Cells
18. Optimization Of CD19 CAR-T Based On CXCL12/CXCR4 To Enhance The Anti-tumor Effect In Lymphoma
19. Study The Efficacy Of ITK Gene-Edited CD19 CAR T Cells On Chronic Lymphocytic Leukemia
20. The Efficacy And Safety Study Of CD19 CAR-T Cells Immunotherapy For Relapse/Refractory Diffuse Large B-cell Lymphoma Patients—A Single Center,Single Arm,Open Clinical Study
  <<First  <Prev  Next>  Last>>  Jump to